T 1021/11 (PCV2 composition/BOEHRINGER INGELHEIM) of 02.06.2015
- European Case Law Identifier
- ECLI:EP:BA:2015:T102111.20150602
- Date of decision
- 2 June 2015
- Case number
- T 1021/11
- Petition for review of
- -
- Application number
- 06850366.3
- IPC class
- A61K 39/12
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
- Applicant name
- Boehringer Ingelheim Vetmedica, Inc.
- Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1) 1973European Patent Convention Art 123(3)European Patent Convention Art 54(1) 1973European Patent Convention Art 54(2) 1973European Patent Convention Art 54(3)European Patent Convention Art 54(4) 1973European Patent Convention Art 54(5)European Patent Convention Art 56 1973European Patent Convention Art 83 1973European Patent Convention Art 84 1973
- Keywords
- Main request: Two independent claims for the same medical use; one claim under the provisions of EPC 1973 invoking legal fiction in G 5/83 and other claim under the provisions of Article 54(5) EPC 2000 (yes)
Main request: allowable (yes) - Catchword
- see points 34 to 49
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the examining division with the order to grant a patent on the basis of claims 1 to 9 of the main request filed with the letter dated 18 December 2014, with a description and figures to be adapted thereto.